Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans

Cited by (982)

Items 701–800 of 982

1. [Body fat percentage and anthropometric parameters in children with obesity].
   Anna Majcher, Beata Pyrżak, Aneta Czerwonogrodzka–Senczyna, Anna Kucharská · 2008 · PubMed
2. Development of a novel virus-like particle-based vaccine for preventing tick-borne encephalitis virus infection
   Jielin Tang, Muqing Fu, Chonghui Xu, Bao Xue, Anqi Zhou, Sijie Chen, He Zhao, Yuan Zhou, Jizheng Chen, Qi Yang et al. · 2023 · Virologica Sinica
3. Influenza Viruses
   John J. Treanor · 2023 · Springer eBooks
4. Airway-resident memory CD4 T cell activation accelerates antigen presentation and T cell priming in draining lymph nodes
   Caroline M. Finn, Kunal Dhume, Eugene Baffoe, Lauren A. Kimball, Tara M. Strutt, Karl Kai McKinstry · 2024 · JCI Insight
5. Formulation and immunological evaluation of a trivalent vaccine comprising emulsified submicron particles and inactivated virions of H5N1/EV71/JEV
   Chih-Wei Lin, Ching-Yun Chang, Weilin Chen, Shih-Chang Lin, Chien-Chun Liao, Jui-Yuan Chang, Chia‐Chyi Liu, Alan Yung-Chih Hu, Tsung-Chun Lu, Ai‐Hsiang Chou et al. · 2013 · Human Vaccines & Immunotherapeutics
6. Influenza – A new pathogen every year
   Rodrigo B. Abreu, Ted M. Ross · 2018 · Current Opinion in Systems Biology
7. Enzymatic Stability and Immunoregulatory Efficacy of a Synthetic Indolicidin Analogue with Regular Enantiomeric Sequence
   Ching-Yun Chang, Chih-Wei Lin, Sheng-Kuo Chiang, Po-Ling Chen, Chiung‐Yi Huang, Shih‐Jen Liu, Pele Choi-Sing Chong, Ming‐Hsi Huang · 2013 · ACS Medicinal Chemistry Letters
8. CD4+ T cells limit the damage in influenza
   Anne Kelso · 2012 · Nature Medicine
9. Programmed Death 1 Regulates Memory Phenotype CD4 T Cell Accumulation, Inhibits Expansion of the Effector Memory Phenotype Subset and Modulates Production of Effector Cytokines
   Joanna J. Charlton, Debbie Tsoukatou, Clio Mamalaki, Ioannis Chatzidakis · 2015 · PLoS ONE
10. Competition within the virus‐specific CD4 T‐cell pool limits the T follicular helper response after influenza infection
    Matthew Richard Olson, Brendon Yew Loong Chua, Kim L. Good‐Jacobson, Peter C. Doherty, David Charles Jackson, Stephen J Turner · 2016 · Immunology and Cell Biology
11. Priming Vaccination With Influenza Virus H5 Hemagglutinin Antigen Significantly Increases the Duration of T cell Responses Induced by a Heterologous H5 Booster Vaccination
    Daniel Fredric Hoft, Kathleen R. Lottenbach, Johannes B. Goll, Heather Hill, Patricia L. Winokur, Shital M. Patel, Rebecca C. Brady, Wilbur H. Chen, Kathryn M. Edwards, Clarence Buddy Creech et al. · 2016 · The Journal of Infectious Diseases
12. Standard-Dose Intradermal Influenza Vaccine Elicits Cellular Immune Responses Similar to Those of Intramuscular Vaccine in Men With and Those Without HIV Infection
    Samuel Amoah, Margarita Mishina, Prabda Praphasiri, Weiping Cao, Jin Hyang Kim, Justine S. Liepkalns, Zhu Guo, Paul J. Carney, Jessie C. Chang, Stefan Fernandez et al. · 2019 · The Journal of Infectious Diseases
13. Effectiveness of adjunctive corticosteroid therapy in patients with severe COVID-19: A retrospective cohort study
    Bin Xiong, Li-Min He, Yuanyuan Qin, Hu Du, Zhu Zhan, Yihong Zhou, Yaokai Chen, An Zhang · 2021 · World Journal of Clinical Cases
14. Robust induction of TRMs by combinatorial nanoshells confers cross-strain sterilizing immunity against lethal influenza viruses
    Pin‐Hung Lin, Chieh-Yu Liang, Bing‐Yu Yao, Hui‐Wen Chen, Ching-Fu Pan, Li‐Ling Wu, Yi-Hsuan Lin, Yu-Sung Hsu, Yu-Han Liu, Pei‐Jer Chen et al. · 2021 · Molecular Therapy — Methods & Clinical Development
15. Clinical, scientific and ethnographic studies of influenza in quarantine
    JOHN S. OXFORD, Juliette R Oxford · 2012 · Expert Review of Vaccines
16. Influenza A(H5N1) Vaccines: Are We Better Prepared for the Next Pandemic?
    W Keitel, Pedro A. Piedra · 2013 · The Journal of Infectious Diseases
17. Naturally-acquired immunity in Syrian Golden Hamsters provides protection from re-exposure to emerging heterosubtypic SARS-CoV-2 variants B.1.1.7 and B.1.351
    Jordan J. Clark, Parul Sharma, Eleanor G. Bentley, Adam C. Harding, Anja Kipar, Megan Neary, Helen Box, Grant L. Hughes, Edward I. Patterson, Joanne Sharp et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
18. Filling two needs with one deed: a combinatory mucosal vaccine against influenza A virus and respiratory syncytial virus
    Ana Vieira Antão, Friederike Oltmanns, Anna P. Schmidt, Vera Viherlehto, Pascal Irrgang, Marie‐Anne Rameix‐Welti, Wibke Bayer, Dennis Lapuente, Matthias Tenbusch · 2024 · Frontiers in Immunology
19. Serum anti-nucleocapsid antibody correlates of protection from SARS-CoV-2 re-infection regardless of symptoms or immune history
    Shô Miyamoto, Koki Numakura, Ryo Kinoshita, Takeshi Arashiro, Hiromizu Takahashi, Hiromi Hibino, Minako Hayakawa, Takayuki Kanno, Akiko Sataka, Rena Sakamoto et al. · 2025 · Communications Medicine
20. Humoral and Cellular Immunity Induced by Adjuvanted and Standard Trivalent Influenza Vaccine in Older Nursing Home Residents
    Carson L. Smith, Beth Bednarchik, Htin Aung, Dennis J. Wilk, Rebecca S. Boxer, Andrea E. Daddato, Brigid M. Wilson, Stefan Gravenstein, David H. Canaday · 2023 · The Journal of Infectious Diseases
21. STAT1 Controls the Functionality of Influenza-Primed CD4 T Cells but Therapeutic STAT4 Engagement Maximizes Their Antiviral Impact
    Caroline M. Finn, Kunal Dhume, Emily Prokop, Tara M. Strutt, Karl Kai McKinstry · 2023 · The Journal of Immunology
22. Analysis of clinical characteristics and risk factors for death due to severe influenza in children
    Ruiyang Sun, Xue Zhang, Wanyu Jia, Peng Li, Chunlan Song · 2024 · European Journal of Clinical Microbiology & Infectious Diseases
23. Induction of Regulatory T Cells After Virus Infection and Vaccination
    Mansoureh Karimi Kakh, Mehrnoosh Doroudchi, Atefe Ghamar Talepoor · 2025 · Immunology
24. Comparing the Immunogenicity of AS03-Adjuvanted 2009 Pandemic H1N1 Vaccine with Clinical Protection in Priority Risk Groups in England
    Chee-Fu Yung, Nick J Andrews, Katja Höschler, Elizabeth Miller · 2013 · PLoS ONE
25. Temporary CXCR3 and CCR5 Antagonism Following Vaccination Enhances Memory CD8 T Cell Immune Responses
    Rui Qiang Li, Nan Zhang, Miaomiao Tian, Zihan Ran, Mingjun Zhu, Haiyan Zhu, Fangting Han, Juan Juan Yin, Jiang Shi Zhong · 2016 · Molecular Medicine
26. Hard-to-kill macrophages lead to chronic inflammation in HIV
    Peter Kelleher, Xiao‐Ning Xu · 2018 · Nature Immunology
27. Prospects for Using the ELISPOT Technological Platform as Part of Anti-Epidemic Measures Against the New Coronavirus Infection COVID-19
    Dmitry A. Poteryaev, Хамитов Равиль Авгатович, Grigory Aleksandrovich Efimov, А. М. Shuster · 2020 · Biological Products Prevention Diagnosis Treatment
28. Human Salmonella Typhi exposure generates differential multifunctional cross‐reactive T‐cell memory responses against Salmonella Paratyphi and invasive nontyphoidal Salmonella
    Rekha R. Rapaka, Rezwanul Wahid, Stéphanie Fresnay, Jayaum S. Booth, Thomas C. Darton, Claire Jones, Claire S. Waddington, Myron M. Levine, Andrew John Pollard, Marcelo B. Sztein · 2020 · Clinical & Translational Immunology
29. An update on studies characterizing adaptive immune responses in SARS-CoV-2 infection and COVID-19 vaccination
    Ricardo da Silva Antunes, Alba Grifoni, April Frazier, Daniela Weiskopf, Alessandro Sette · 2023 · International Immunology
30. Assessment of the cytolytic potential of a multivirus-targeted T cell therapy using a vital dye-based, flow cytometric assay
    Kiriakos Koukoulias, Penelope Georgia Papayanni, Julia L. Jones, Manik Kuvalekar, Ayumi Watanabe, Yovana Velazquez, Sarah A. Gilmore, Αναστασία Παπαδοπούλου, Ann Marie Leen, Spyridoula Vasileiou · 2023 · Frontiers in Immunology
31. Heterologous protection elicited by candidate monomeric recombinant HIV-1 gp120 vaccine in the absence of cross neutralising antibodies in a macaque model
    Mark Page, Richard Stebbings, Neil J. Berry, Robin Hull, Deborah Ferguson, Leanne Davis, Laura Duffy, William Elsley, Joanna Hall, Claire Ham et al. · 2012 · Retrovirology
32. Using Clinical Trial Simulators to Analyse the Sources of Variance in Clinical Trials of Novel Therapies for Acute Viral Infections
    Carolin Vegvari, Emilie Cauët, Christoforos Hadjichrysanthou, Emma Lawrence, Gerrit Jan Weverling, Frank de Wolf, Roy Malcolm Anderson · 2016 · PLoS ONE
33. Enhancing the Yield and Quality of Influenza Virus-like Particles (VLPs) Produced in Insect Cells by Inhibiting Cytopathic Effects of Matrix Protein M2
    Andrew J. Zak, Brett Hill, Syed Monem Rizvi, Mason R. Smith, Madeleine Yang, Fei Wen · 2019 · ACS Synthetic Biology
34. Humoral and cellular immune responses in critically ill influenza A/H1N1‐infected patients
    Abira Paramsothy, Sarah Larteley Lartey, Richard Davies, A. B. Guttormsen, Rebecca Jane Cox, Kristin Greve-Isdahl Mohn · 2021 · Scandinavian Journal of Immunology
35. Cell‐mediated immunity
    Stephen J. Turner, Peter C. Doherty, Anne Kelso · 2013
36. The Dynamics of Influenza A H3N2 Defective Viral Genomes from a Human Challenge Study
    Michael A. Martin, Drishti Kaul, Gene S. Tan, Christopher W. Woods, Katia Koelle · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
37. A targeted single mutation in influenza A virus universal epitope transforms immunogenicity and protective immunity via CD4+ T cell activation
    Sarah L. Hulin-Curtis, James K. Geary, Bruce J. MacLachlan, Daniel Martin Altmann, Laury Baillon, David K. Cole, Alexander Greenshields‐Watson, Sophie J. Hesketh, Ian Robert Humphreys, Ian Martin Jones et al. · 2024 · Cell Reports
38. Aerosol immunization with influenza matrix, nucleoprotein, or both prevents lung disease in pig
    Eleni Vatzia, Basudev Paudyal, Bárbara Dema, Brigid Veronica Carr, Ehsan Sedaghat-Rostami, Simon Gubbins, Bhawna Sharma, Elliot Moorhouse, Susan Morris, Marta Ulaszewska et al. · 2024 · npj Vaccines
39. Development of universal influenza vaccines: strategies for broadly cross-reactive influenza vaccine responses
    Mengling Li, Pengju Guo, Haiguang Song, Cen Chen, Hongbo Zhou, Tao Pan · 2025 · Animal Diseases
40. Functionality and avidity of norovirus-specific antibodies and T cells induced by GII.4 virus-like particles alone or co-administered with different genotypes
    Maria Malm, Kirsi Tamminen, Suvi Heinimäki, Timo Vesikari, Vesna Blazevic · 2017 · Vaccine
41. A polyvalent virosomal influenza vaccine induces broad cellular and humoral immunity in pigs
    Vanessa Haach, Ana Paula Almeida Bastos, Danielle Gava, Francisco Noé da Fonseca, M. A. Z. Morés, Arlei Coldebella, Ana Cláudia Franco, Rejane Schaefer · 2023 · Virology Journal
42. Diversifying T-cell responses: safeguarding against pandemic influenza with mosaic nucleoprotein
    Hong-Tae Park, Brock A. Kingstad-Bakke, Thomas Cleven, Myunghwan Jung, Yoshihiro Kawaoka, M. Suresh · 2025 · Journal of Virology
43. T cell epitope mapping reveals immunodominance of evolutionarily conserved regions within SARS-CoV-2 proteome
    Cansu Cimen Bozkus, Matthew Brown, Leandra G. Velazquez, Marcus Thomas, Eric A. Wilson, Timothy J. O’Donnell, Anna Kaminska, Denis Ruchnewitz, Douglas Geertz, Yonina Bykov et al. · 2025 · iScience
44. Mucosal delivery of a combination adjuvant comprising emulsified fine particles and LD-indolicidin enhances serological immunity to inactivated influenza virus
    Ming‐Hsi Huang, Shih-Hsiung Dai, Pele Choi-Sing Chong · 2016 · Microbes and Infection
45. Surveillance Study of Influenza Occurrence and Immunity in a Wisconsin Cohort During the 2009 Pandemic
    Chia-Yun Lo, Susan L. Strobl, KIMBERLY R. DUNHAM, Wei Wang, Lucy Stewart, Julia A. Misplon, Mayra García, Jin Gao, Tatsuhiko Ozawa, Graeme E. Price et al. · 2017 · Open Forum Infectious Diseases
46. Long-lasting protective immunity against H7N9 infection is induced by intramuscular or CpG-adjuvanted intranasal immunization with the split H7N9 vaccine
    Ya Zhou, Shuxiang Li, Shuai Bi, Ning Li, Yuhai Bi, Wenjun Liu, Beinan Wang · 2019 · International Immunopharmacology
47. Universally Immune: How Infection Permissive Next Generation Influenza Vaccines May Affect Population Immunity and Viral Spread
    Maireid B. Bull, Carolyn A. Cohen, Nancy Leung, Sophie A. Valkenburg · 2021 · Viruses
48. Influenza Virus
    Frederick G. Hayden, Peter Palese · 2016 · ASM Press eBooks
49. Strong CD4+ T-Cell Responses to Ancestral and Variant Spike Proteins Are Established by NVX-CoV2373 Severe Acute Respiratory Syndrome Coronavirus 2 Primary Vaccination
    Louis F Fries, Neil T. Formica, Raburn M. Mallory, Haixia Zhou, Joyce S. Plested, Raj Kalkeri, Ioana Mădălina Moldovan, Nita Patel, Gary R. Albert, Michelle Robinson et al. · 2023 · The Journal of Infectious Diseases
50. Vaccine induced memory CD8+ T cells efficiently prevent viral transmission from the respiratory tract
    Jinglin Zhou, Ida Elin Maria Uddback, Jacob E. Kohlmeier, Jan Pravsgaard Christensen, Allan Randrup Thomsen · 2023 · Frontiers in Immunology
51. Evolution of protective SARS-CoV-2-specific B and T cell responses upon vaccination and Omicron breakthrough infection
    Mohamed I. M. Ahmed, Sebastian Einhauser, Clemens Peiter, Antonia Senninger, Olga Baranov, Tabea M. Eser, Manuel Huth, Laura Olbrich, Noemi Castelletti, Raquel Rubio‐Acero et al. · 2024 · iScience
52. Naturally-Acquired Influenza-Specific CD4+ T-Cell Proliferative Responses Are Impaired in HIV-Infected African Adults
    Kondwani Jambo, Enoch Sepako, Sarah J. Glennie, David Twapokera Mzinza, Neil Williams, Stephen B. Gordon, Robert S. Heyderman · 2012 · PLoS ONE
53. B Cell–Specific Biomarkers for Optimal Antibody Responses to Influenza Vaccination and Molecular Pathways That Reduce B Cell Function with Aging
    Daniela Frasca, Bonnie B. Blomberg · 2016 · Critical Reviews in Immunology
54. Influenza virus infection as well as immunization with DNA encoding haemagglutinin protein induces potent antibody-dependent phagocytosis (ADP) and monocyte infection-enhancing responses in macaques
    Gerrit Koopman, Daniëlla Mortier, Samira Michels, Sam Hofman, Zahra C. Fagrouch, Edmond J. Remarque, Ernst J. Verschoor, Petra Mooij, Willy M J M Bogers · 2019 · Journal of General Virology
55. Age-Based Dynamics of a Stable Circulating Cd8 T Cell Repertoire Component
    Elena N. Naumova, Maryam B. Yassai, Wendy Demos, E.F. Reed, Melissa Unruh, Dipica Haribhai, Calvin B. Williams, Yuri N. Naumov, Jack Gorski · 2019 · Frontiers in Immunology
56. Prior Infection of Chickens with H1N1 or H1N2 Avian Influenza Elicits Partial Heterologous Protection against Highly Pathogenic H5N1
    Charles K Nfon, Yohannes Berhane, John M.M. Pasick, Carissa Embury‐Hyatt, Gary Kobinger, Darwyn Kobasa, Shawn Babiuk · 2012 · PLoS ONE
57. The effect of splenectomy on the levels of PCV-13-induced memory B- and T cells
    Umut Gazi, Djursun Karasartova, İbrahim Tayfun Şahiner, Ayşe Semra Güreser, Özgür Tosun, Mehmet Kürşat Derici, Mete Dolapçı, Ayşegül Taylan Özkan · 2018 · International Journal of Clinical Practice
58. Deciphering the ins and outs of SARS-CoV-2-specific T cells
    André Perez‐Potti, Joshua L. Lange, Marcus Buggert · 2020 · Nature Immunology
59. OLYMPUS: An automated hybrid clustering method in time series gene expression. Case study: Host response after Influenza A (H1N1) infection
    Konstantina Dimitrakopoulou, Aristidis G. Vrahatis, Esther Wilk, Athanasios K. Tsakalidis, Anastasios Bezerianos · 2013 · Computer Methods and Programs in Biomedicine
60. Improved cross-protection and immunity against influenza A virus in mice using a novel mRNA vaccine with optimized design of RNA sequence
    Tangqi Wang, Ruiwen Han, Zhanyihao Hao, Xueting Cheng, Jia Li, Chengcheng Zhai, Junjia Guo, Donghong Wang, Yao Deng, Liang Zhang et al. · 2025 · Molecular Therapy — Nucleic Acids
61. Cytotoxic CD4+ T cells in cancer: an emerging target for next-generation anticancer immunotherapy?
    Imke van Wandeloo, Kalijn F. Bol, Carla van Herpen, I. Jolanda de Vries, Gerty Schreibelt · 2025 · Journal for ImmunoTherapy of Cancer
62. On the feasibility of using TCR sequencing to follow a vaccination response – lessons learned
    Peter C. de Greef, Josien Lanfermeijer, Marion Hendriks, Alper Çevirgel, Martijn W. Vos, José A. M. Borghans, Debbie van Baarle, Rob J. de Boer · 2023 · Frontiers in Immunology
63. Evaluation of Safety, Immunogenicity and Cross-Reactive Immunity of OVX836, a Nucleoprotein-Based Universal Influenza Vaccine, in Older Adults
    Bart Jacobs, Isabel Leroux‐Roels, Jacques Bruhwyler, Nicola Groth, Gwenn Waerlop, Yorick Janssens, Jessika Tourneur, Fien De Boever, Azhar Alhatemi, Philippe Moris et al. · 2024 · Vaccines
64. T-cell immunity against influenza virus does not require Th1 or Th17 master regulator transcription factors
    Kunal Dhume, Caroline M. Finn, Eugene Baffoe, Lauren A. Kimball, Siva N. Annamalai, Verónica Urdaneta-Páez, Jash Trivedi, Taj Azarian, Tara M. Strutt, Karl Kai McKinstry · 2025 · Mucosal Immunology
65. Human Cytomegalovirus pUL11, a CD45 Ligand, Disrupts CD4 T Cell Control of Viral Spread in Epithelial Cells
    Samuel Ayodeji Osanyinlusi, Jasmin Zischke, Roland Jacobs, Eva M. Weissinger, Thomas Friedrich Schulz, Penelope C. Kay-Fedorov · 2022 · mBio
66. Superior antibody and membrane protein-specific T-cell responses to CoronaVac by intradermal versus intramuscular routes in adolescents
    Jaime S. Rosa Duque, Samuel M. S. Cheng, Carolyn A. Cohen, Daniel Leung, Xiwei Wang, Xiaofeng Mu, Yuet Chung, Tsun Ming Lau, Manni Wang, Wenyue Zhang et al. · 2023 · World Journal of Pediatrics
67. Immunogenicity of chimeric hemagglutinins delivered by an orf virus vector platform against swine influenza virus
    Gabriela Mansano do Nascimento, Pablo Sebastian Britto de Oliveira, Salman Latif Butt, Diego G. Diel · 2024 · Frontiers in Immunology
68. Influenza vaccines and immunopathology
    Sarah C. Gilbert · 2012 · Expert Review of Vaccines
69. The challenges of creating a universal influenza vaccine
    Andrej Egorov · 2016 · Microbiology Independent Research Journal (MIR Journal)
70. Exploring the Potential of T-Cells for a Universal Influenza Vaccine
    Sharon Vijayanand, Keegan Braz Gomes, Rikhav P. Gala, Mohammad Nasir Uddin, Martin J. D’Souza · 2020 · Vaccines
71. Differentiating severe and non-severe lower respiratory tract illness in patients hospitalized with influenza: Development of the Influenza Disease Evaluation and Assessment of Severity (IDEAS) scale
    Eric J. Chow, Mark W. Tenforde, Melissa A R Rolfes, Benjamin Lee, Shreya Chodisetty, Julio A. Ramírez, Alicia M. Fry, Manish M. Patel · 2021 · PLoS ONE
72. Bystander activation of tissue‐resident memory CD4 T cells: Getting by with a little help from unfamiliar T‐cell friends
    Rebecca Cornelis, Ziv Shulman · 2023 · European Journal of Immunology
73. Protective Efficacy of a Mucosal Influenza Vaccine Formulation Based on the Recombinant Nucleoprotein Co-Administered with a TLR2/6 Agonist BPPcysMPEG
    María Victoria Sánchez, Thomas Ebensen, Kai Schulze, Diego Esteban Cargnelutti, Eduardo Alberto Scodeller, Carlos A. Guzmán · 2023 · Pharmaceutics
74. Multifunctional cytokine production marks influenza A virus‐specific CD4 T cells with high expression of survival molecules
    Lotus M Westerhof, Jonathan Edward Noonan, Kerrie E Hargrave, Elizabeth T. Chimbayo, Zhiling Cheng, Thomas Purnell, Mark R. Jackson, Nicholas C. Borcherding, Megan K. L. MacLeod · 2023 · European Journal of Immunology
75. Mass Cytometry Defines Virus-Specific CD4+ T Cells in Influenza Vaccination
    Priyanka B. Subrahmanyam, Tyson H. Holmes, Dongxia Lin, Laura F. Su, Gerlinde Obermoser, Jacques Banchereau, Virginia Pascual, Adolfo García‐Sastre, Randy A. Albrecht, Karolina Palucka et al. · 2020 · ImmunoHorizons
76. Seasonal influenza vaccines and hurdles to mutual protection
    Christopher Chiu · 2016 · Clinical Microbiology and Infection
77. Broad-Based CD4+ T Cell Responses to Influenza A Virus in a Healthy Individual Who Lacks Typical Immunodominance Hierarchy
    Li Chen, Anjaleena Anthony, Sara Oveissi, Miaojuan Huang, Damien J. Zanker, Kun Xiao, Chao Wu, Quanming Zou, Weisan Chen · 2017 · Frontiers in Immunology
78. Influenza Viruses
    John J. Treanor · 2014 · Springer eBooks
79. Influenza
    Gabriele Neumann, Benjamin John Cowling, Hualan Chen, Silke Stertz, Balaji Manicassamy, Ian Barr, Timothy M. Uyeki, Yoshihiro Kawaoka · 2026 · Nature Reviews Disease Primers
80. Safety and Immunogenicity of OVX836, a Nucleoprotein-Based Universal Influenza Vaccine, Co-Administered with Fluarix® Tetra, a Seasonal Hemagglutinin-Based Vaccine
    Nicola Groth, Jacques Bruhwyler, Jessika Tourneur, Emilie Piat, Philippe Moris, Alexandre Le Vert, Florence Nicolas · 2025 · Vaccines
81. High-dimensional single-cell phenotyping unveils persistent differences in immune cell profiles between severe and moderate seasonal influenza
    Johanna Bodin, Gro Tunheim, Anja Bråthen Kristoffersen, Tove Karin Herstad, Eleonora Vianello, Mariëlle C. Haks, Suzanne van Veen, Torgun Wæhre, Anne‐Marte Bakken Kran, Sarah Larteley Lartey et al. · 2025 · Frontiers in Immunology
82. Expansion of a distinct cytotoxic CD4 TFH-cell cluster in lymph nodes of patients with complicated common variable immunodeficiency
    David Friedmann, Kathryn J. Payne, Victoria N. Cousin, Geoffroy Andrieux, Ke Meng, Alexandra Emilia Schlaak, Susanne Unger, Adam Klocperk, Christoph B. Geier, Katja Gräwe et al. · 2025 · Journal of Allergy and Clinical Immunology
83. Modified influenza M158–66 peptide vaccination induces non-relevant T-cells and may enhance pathology after challenge
    Josien Lanfermeijer, Koen van de Ven, Harry van Dijken, Marion Hendriks, Cami M. P. Talavera Ormeño, Femke de Heij, Paul J. M. Roholl, José A. M. Borghans, Debbie van Baarle, Jørgen de Jonge · 2023 · npj Vaccines
84. Advancing universal influenza vaccines: insights from cellular immunity targeting the conserved hemagglutinin stalk domain in humans
    Chunhong Dong, Bao‐Zhong Wang · 2024 · EBioMedicine
85. Lung influenza virus-specific memory CD4 T cell location and optimal cytokine production are dependent on interactions with lung antigen-presenting cells
    Kerrie E Hargrave, Julie C. Worrell, Chiara Pirillo, Euan Brennan, Andreu Masdefiol Garriga, Joshua I. Gray, Thomas Purnell, Edward W. Roberts, Megan K. L. MacLeod · 2024 · Mucosal Immunology
86. Immunological characteristics of a recombinant alphaherpesvirus with an envelope-embedded Cap protein of circovirus
    Chenhe Lu, Haimin Li, Wenjing Chen, Hui Li, Jiayu Ma, Peng Peng, Yan Yan, Wei-Ren Dong, Yulan Jin, Shiyue Pan et al. · 2024 · Frontiers in Immunology
87. Immune responses and transcription landscape of adults with the third dose of homologous and heterologous booster vaccines of COVID-19
    Hui Zheng, Cuidan Li, Xiuyu Zheng, Hu-Dachuan Jiang, Yuqing Li, Aihua Yao, Xiaolong Li, Feiyu Wang, Wenqing Liu, Xiang Cao et al. · 2024 · Frontiers in Immunology
88. Broad Mucosal and Systemic Immunity in Mice Induced by Intranasal Booster With a Novel Recombinant Adenoviral Based Vaccine Protects Against Divergent Influenza A Virus
    Jia Li, Tangqi Wang, Xiaojuan Guo, Yujie Jiang, Liye Jin, Qiaohong Chu, Xuchang Shan, Lingfang Zhang, Ruiwen Han, Chengcheng Zhai et al. · 2025 · Journal of Medical Virology
89. Baseline Levels of Influenza-Specific B Cells and T Cell Responses Modulate Human Immune Responses to Swine Variant Influenza A/H3N2 Vaccine
    Lilin Lai, Nadine Rouphael, Yongxian Xu, Amy C Sherman, Srilatha Edupuganti, Evan J. Anderson, Pamela Lankford-Turner, Dongli Wang, Wendy A. Keitel, Monica McNeal et al. · 2020 · Vaccines
90. Susceptibility identification for seasonal influenza A/H3N2 based on baseline blood transcriptome
    Jing Yan Tang, Qiumei Xu, Kang Tang, Xiaoyan Ye, Zicheng Cao, Min Zou, Jinfeng Zeng, Xinyan Guan, Jinglin Han, Yihan Wang et al. · 2023 · Frontiers in Immunology
91. Intermediate Levels of Pre-Existing Protective Antibody Allow Priming of Protective T Cell Immunity against Influenza
    Terry Ng, Valeria Flores-Malavet, Mishfak A. M. Mansoor, Andrea C. Arvelo, Kunal Dhume, Emily Prokop, Karl Kai McKinstry, Tara M. Strutt · 2023 · The Journal of Immunology
92. Tracking of activated cTfh cells following sequential influenza vaccinations reveals transcriptional profile of clonotypes driving a vaccine-induced immune response
    Jennifer Currenti, Joshua D. Simmons, Jared M. Oakes, Silvana Gaudieri, Christian M. Warren, Rama Gangula, Eric Alves, Ramesh Ram, Shay Leary, Jesse D. Armitage et al. · 2023 · Frontiers in Immunology
93. Highly Networked SARS-CoV-2 Peptides Elicit T Cell Responses with Enhanced Specificity
    Gabriel Duette, Eunok Lee, Gabriela Martins Costa Gomes, Katie Tungatt, Chloe M. Doyle, Vicki V Stylianou, Ashley Lee, Susan Maddocks, Janette Taylor, Rajiv Khanna et al. · 2023 · ImmunoHorizons
94. Correlates of Protection
    Stanley Alan Plotkin, Peter B. Gilbert · 2023 · Elsevier eBooks
95. ΔA146Ply-HA stem protein immunization protects mice against influenza A virus infection and co-infection with Streptococcus pneumoniae
    Lian Li, Ting Guo, Yuan Yuan, Jiangming Xiao, Rui Yang, Hanyi Wang, Wenlong Xu, Yibing Yin, Xuemei Zhang · 2023 · Molecular Immunology
96. Influenza virus infections: clinical update, molecular biology, and therapeutic options
    Gianluigi Franci, Luciana Palomba, Annarita Falanga, Carla Zannella, Vera D’Oriano, Luca Rinaldi, Stefania Galdiero, Massimiliano Galdiero · 2016 · Elsevier eBooks
97. A Comprehensive Analysis of the Impact of HIV on HCV Immune Responses and Its Association with Liver Disease Progression in a Unique Plasma Donor Cohort
    Yonghong Zhang, Yan Zhao, Ushani Rajapaksa, Tessa M. Lawrence, Yanchun Peng, Jinghua Liu, Keyi Xu, Ke Hu, Ling Qin, Ning Liu et al. · 2016 · PLoS ONE
98. Prior exposure to immunogenic peptides found in human influenza A viruses may influence the age distribution of cases with avian influenza H5N1 and H7N9 virus infections
    Naomi Komadina, Sheena G. Sullivan, Katherine Kedzierska, Sergio M. Quiñones‐Parra, Karin S Leder, Jodie McVernon · 2019 · Epidemiology and Infection
99. Early T Cell Differentiation with Well-Maintained Function across the Adult Life Course in Sub-Saharan Africa
    David J. C. Miles, Florence Shumba, Annette Pachnio, Jusnara Begum, Elizabeth Lucy Corbett, Robert S. Heyderman, Paul A. H. Moss · 2019 · The Journal of Immunology
100. Vaccinia Virus Vectors Targeting Peptides for MHC Class II Presentation to CD4+ T Cells
     Samuel J. Hobbs, Jake C. Harbour, Phillip A. Yates, Diana Ortiz, Scott M. Landfear, Jeffrey C. Nolz · 2020 · ImmunoHorizons